INT110716

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.26
First Reported 2003
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 1.21
Pain Relevance 0.17

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
blood 1
Cm3 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
anesthesia 1 97.52 Very High Very High Very High
Pain 1 77.08 Quite High
depression 6 5.00 Very Low Very Low Very Low
withdrawal 2 5.00 Very Low Very Low Very Low
Neurotransmitter 1 5.00 Very Low Very Low Very Low
Dysuria 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Benign Prostatic Hypertrophy 52 100.00 Very High Very High Very High
Pressure Volume 2 Under Development 4 100.00 Very High Very High Very High
Hematuria 16 97.84 Very High Very High Very High
Reprotox - General 1 39 97.28 Very High Very High Very High
Reprotox - General 2 11 88.44 High High
Pain 1 77.08 Quite High
Overactive Bladder 15 69.24 Quite High
Cancer 10 19.76 Low Low
Depression 6 5.00 Very Low Very Low Very Low
Disease 6 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Patient and operative factors were analyzed by intent to treat; the major endpoints were operating room (OR) time in minutes, blood loss in cm3, length of hospital stay in days, and charges broken down by anesthesia/operation [OR/recovery room (RR)] and total charges in dollars x 1000.
Negative_regulation (loss) of cm3 in blood associated with anesthesia and pressure volume 2 under development
1) Confidence 0.26 Published 2003 Journal Am Surg Section Abstract Doc Link 12769207 Disease Relevance 0.18 Pain Relevance 0.17
In conclusion, finasteride represents a cost-effective means of reducing BPH progression and its complications in men with enlarged prostates >30 cm3 while providing the additional benefits of decreased hematuria and prostate cancer rates.



Negative_regulation (reducing) of cm3 associated with benign prostatic hypertrophy, reprotox - general 1 and hematuria
2) Confidence 0.03 Published 2009 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2710385 Disease Relevance 1.03 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox